Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP14 | P50281 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7565445 | 0.79 | LTA4H (0.39) | MEN1KMT2ACYP1A2CYP2C19 | |
| SCHEMBL22382283 | 0.79 | ALDH1A1 (0.52) | MAPTALDH1A1KDM4EMEN1POLB | |
| SCHEMBL7558830 | 0.78 | CYP17A1 (0.40) | MAPTMEN1GAARAB9AKMT2A | |
| SCHEMBL7560691 | 0.75 | ESR2 (0.39) | CYP1A2CYP2C19 | |
| SCHEMBL7558569 | 0.73 | CYP17A1 (0.36) | MAPTGAARAB9ACYP2C9CYP1A2 | |
| SCHEMBL6973054 | 0.72 | LTA4H (0.34) | CYP1A2CYP2C19 | |
| SCHEMBL9122253 | 0.72 | NPC1 (0.37) | MAPTKDM4EMEN1RAB9AKMT2A | |
| SCHEMBL22032571 | 0.72 | POLB (0.50) | MAPTKDM4EPOLB | |
| SCHEMBL8542097 | 0.70 | ESR2 (0.37) | CYP1A2CYP2C19 | |
| SCHEMBL31339539 | 0.69 | MEN1 (0.48) | MAPTALDH1A1KDM4EMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9117475-B2 | Lubricant composition and use thereof | FUJIFILM CORPORATION (JP) | 2015-08-25 | — | — | US | disclosed |
| EP-2412789-A1 | LUBRICANT COMPOSITION AND USE THEREOF | FUJIFILM Corporation (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-20120021253-A1 | LUBRICANT COMPOSITION AND USE THEREOF | FUJIFILM CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120021253-A1 | LUBRICANT COMPOSITION AND USE THEREOF | MUC1, F12, SFN | MAPT 3406/4885ALDH1A1 3731/4885KDM4E 4221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.